 |
|
|
 |
FDA approves drug for neuropathic pain associated with diabetes
Earlier this week, the Food and Drug Administration (FDA) announced the approval of Cymbalta (duloxetine hydrochloride) capsules for the management of the pain associated with diabetic peripheral neuropathy. This is the first drug specifically approved for this indication. Cymbalta received a priority review. more
|
|
Prescribing information: Cymbalta (duloxetine hydrochloride)
Cymbalta is indicated for the treatment of major depressive disorder, as well as for the management of diabetic peripheral neuropathic pain (DPNP). more
|
|
Centers report islet transplant results in patients with type 1 diabetes
Researchers from 12 medical centers in the United States and Canada, who have performed islet transplants in 86 patients with type 1 diabetes, published their results today in the first annual report of the Collaborative Islet Transplant Registry (CITR). more
|
|
|
|
B cells gone bad: Researchers uncover how HIV causes abnormalities in antibody-producing cells
HIV wreaks much of its damage by targeting the "orchestra conductor" of the immune system, a key class of T cells -- CD4+ T cells -- whose destructive relationship with HIV has been well-studied by AIDS researchers. More poorly understood has been the effect of HIV on another key class of immune cells, antibody-producing B cells. more
|
|
Doctors writing new prescriptions -- for using the Internet
A University of Iowa study shows that the nearly no-cost, quick effort is an effective way to put people in touch with quality health information on the Internet. The finding, based on a study of pediatricians and families at one hospital, appears in the September issue of the Archives of Pediatrics and Adolescent Medicine. more
|
|
New genetic hypothesis for the cause of autism
Researchers have proposed a new hypothesis on the cause of autism, suggesting a mixed epigenetic and genetic and mixed de novo and inherited (MEGDI) model. Their hypothesis, and evidence to support it, will be published September 8, 2004 in the online edition of the American Journal of Medical Genetics Part A. more
|
|
The promise of personalized medicine
A new technology developed by scientists at IBM could bring the promise of personalized medicine one step closer to reality. more
|
|
|
